Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000891293-14-000028
Filing Date
2014-09-19
Accepted
2014-09-19 19:18:07
Documents
1
Period of Report
2014-09-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 17430
  Complete submission text file 0000891293-14-000028.txt   18896
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Issuer) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 ELLIOT AVENUE WEST SUITE 400 SEATTLE WA 98119
Business Address
BIANCO LOUIS A (Reporting) CIK: 0001204260 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12465 | Film No.: 141112842